261 related articles for article (PubMed ID: 23319595)
1. The MLK-related kinase (MRK) is a novel RhoC effector that mediates lysophosphatidic acid (LPA)-stimulated tumor cell invasion.
Korkina O; Dong Z; Marullo A; Warshaw G; Symons M; Ruggieri R
J Biol Chem; 2013 Feb; 288(8):5364-73. PubMed ID: 23319595
[TBL] [Abstract][Full Text] [Related]
2. Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC.
Wu D; Asiedu M; Wei Q
Oncogene; 2009 Jun; 28(22):2219-30. PubMed ID: 19421144
[TBL] [Abstract][Full Text] [Related]
3. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
[TBL] [Abstract][Full Text] [Related]
4. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer.
Kamai T; Tsujii T; Arai K; Takagi K; Asami H; Ito Y; Oshima H
Clin Cancer Res; 2003 Jul; 9(7):2632-41. PubMed ID: 12855641
[TBL] [Abstract][Full Text] [Related]
5. Cooperation of G12/13 and Gi proteins via lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Biochem Biophys Res Commun; 2020 Nov; 532(3):427-432. PubMed ID: 32883524
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma.
Horiuchi A; Imai T; Wang C; Ohira S; Feng Y; Nikaido T; Konishi I
Lab Invest; 2003 Jun; 83(6):861-70. PubMed ID: 12808121
[TBL] [Abstract][Full Text] [Related]
7. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
Wang L; Yang L; Luo Y; Zheng Y
J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
[TBL] [Abstract][Full Text] [Related]
8. RhoGDIα-dependent balance between RhoA and RhoC is a key regulator of cancer cell tumorigenesis.
Giang Ho TT; Stultiens A; Dubail J; Lapière CM; Nusgens BV; Colige AC; Deroanne CF
Mol Biol Cell; 2011 Sep; 22(17):3263-75. PubMed ID: 21757538
[TBL] [Abstract][Full Text] [Related]
9. LPA, HGF, and EGF utilize distinct combinations of signaling pathways to promote migration and invasion of MDA-MB-231 breast carcinoma cells.
Harrison SM; Knifley T; Chen M; O'Connor KL
BMC Cancer; 2013 Oct; 13():501. PubMed ID: 24160245
[TBL] [Abstract][Full Text] [Related]
10. Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration.
Casteel DE; Turner S; Schwappacher R; Rangaswami H; Su-Yuo J; Zhuang S; Boss GR; Pilz RB
J Biol Chem; 2012 Nov; 287(45):38367-78. PubMed ID: 22992742
[TBL] [Abstract][Full Text] [Related]
11. Integrin α6β4 cooperates with LPA signaling to stimulate Rac through AKAP-Lbc-mediated RhoA activation.
O'Connor KL; Chen M; Towers LN
Am J Physiol Cell Physiol; 2012 Feb; 302(3):C605-14. PubMed ID: 22049212
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of expression of RhoA (RhoC and their effector ROCK-1 with malignant phenotype of ovarian cancer cells in vitro].
Han ZQ; Zhang AL; Wu MF; Liu YL; Chen G; Li FJ; Gao QL; Liao GN; Lu YP; Wang SX; Ma D
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):385-8. PubMed ID: 15355639
[TBL] [Abstract][Full Text] [Related]
13. RhoA and RhoC have distinct roles in migration and invasion by acting through different targets.
Vega FM; Fruhwirth G; Ng T; Ridley AJ
J Cell Biol; 2011 May; 193(4):655-65. PubMed ID: 21576392
[TBL] [Abstract][Full Text] [Related]
14. A p27(kip1)-binding protein, p27RF-Rho, promotes cancer metastasis via activation of RhoA and RhoC.
Hoshino D; Koshikawa N; Seiki M
J Biol Chem; 2011 Jan; 286(4):3139-48. PubMed ID: 21087931
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of adenovirus mediated tandem expression of RhoA and RhoC shRNAs in HCT116 cells.
Liu XP; Wang HB; Yang K; Sui AH; Shi Q; Qu S
J Exp Clin Cancer Res; 2009 Apr; 28(1):52. PubMed ID: 19374769
[TBL] [Abstract][Full Text] [Related]
17. Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer.
Zeng Y; Xie H; Qiao Y; Wang J; Zhu X; He G; Li Y; Ren X; Wang F; Liang L; Ding Y
Cancer Sci; 2015 Oct; 106(10):1385-93. PubMed ID: 26258642
[TBL] [Abstract][Full Text] [Related]
18. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
19. Specific induction of migration and invasion of pancreatic carcinoma cells by RhoC, which differs from RhoA in its localisation and activity.
Dietrich KA; Schwarz R; Liska M; Grass S; Menke A; Meister M; Kierschke G; Längle C; Genze F; Giehl K
Biol Chem; 2009 Oct; 390(10):1063-77. PubMed ID: 19642867
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid stimulates PC-3 prostate cancer cell Matrigel invasion through activation of RhoA and NF-kappaB activity.
Hwang YS; Hodge JC; Sivapurapu N; Lindholm PF
Mol Carcinog; 2006 Jul; 45(7):518-29. PubMed ID: 16402387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
